HR 5239 United States House · 119th Congress

Endometrial Cancer Research and Education Act of 2025

The Endometrial Cancer Research and Education Act of 2025 requires the National Institutes of Health (NIH) to expand research on endometrial cancer, ensure African-American women are represented in clinical trials proportional to their higher incidence rates, and coordinate with health agencies focusing on minority health and women’s health. It also directs the Centers for Disease Control and Prevention (CDC) to develop public education materials about endometrial cancer risk factors, treatments, and disparities, with specific resources targeted to African-American women. The bill authorizes $1 million annually for NIH research and necessary funding for CDC programs from 2026 through 2028. These measures directly affect federal health agencies and aim to address documented disparities in diagnosis and mortality rates among women, particularly African-American women.
Bill status in committee 1 of 4 stages cleared
Introduction
Sep 2025
Committee Review
Floor Vote
President
Introduced Sep 9, 2025 Last action Sep 9, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Sep 9, 2025
Committee
Referred to the House Committee on Energy and Commerce.
lower
Sep 9, 2025
Introduced
Introduced in House
lower
1 primary · 8 co-sponsors

Sponsors